24/7 Emergency & General Advisory
🚨 24/7 Medical Emergency
Non-Emergency Advisory
10:00 AM – 6:00 PM, Mon–Sat
For appointments & general queries.
Join our healthcare community
Stay updated with our latest healthcare news and your appointments.
The PSA test is a blood test used to help screen for prostate cancer before symptoms appear. But PSA is not a cancer diagnosis. Levels can rise because of prostate enlargement, inflammation, infection and other non-cancerous conditions.

PSA stands for prostate-specific antigen, a protein produced by cells in the prostate gland. A small amount of PSA normally circulates in the blood, where it can be measured with a simple blood test.
Doctors use PSA testing as one tool for detecting prostate cancer early, including in men who have no symptoms. But PSA is not specific to cancer. An enlarged prostate, prostatitis and other prostate conditions can also raise the level.
Doctar's at-home PSA testing guide also explains what PSA measures and why an elevated result does not automatically mean cancer.
PSA screening can find prostate cancer earlier, but earlier detection is not always the same as better health outcomes for every man.
Some prostate cancers grow so slowly that they would never cause symptoms or threaten a man's life. Finding these cancers can lead to anxiety, additional testing and treatment that may not have been necessary.
Treatment can also have consequences, including urinary, bowel and sexual side effects.
That is why major medical organisations emphasise shared decision-making rather than telling every man to have routine PSA testing. The American Cancer Society says men should discuss the potential benefits, risks and uncertainties with a healthcare professional before deciding.
There is no single starting age that applies to every man.
The American Cancer Society recommends discussing screening around:
Age 50: men at average risk who are expected to live at least another 10 years
Age 45: men at higher risk, including Black men and those with a father or brother diagnosed with prostate cancer before age 65
Age 40: men at particularly high risk, such as those with more than one first-degree relative diagnosed early
The American Urological Association's guidance is somewhat different. It says clinicians may begin screening and offer a baseline PSA between 45 and 50 for average-risk people, while recommending screening every 2–4 years for people aged 50–69, with earlier screening for those at increased risk.
These differences are exactly why a personal discussion with a doctor is useful.
Age is the strongest risk factor, but it is not the only one.
A man may have a higher risk because of:
a father or brother with prostate cancer
multiple close relatives with prostate cancer
Black ancestry
certain inherited gene changes, including some BRCA-related mutations
other personal or family cancer history
The American Cancer Society recommends earlier screening discussions for men at higher risk.
If prostate cancer runs in your family, don't wait until an arbitrary age to ask about screening.
PSA is usually reported in nanograms per millilitre (ng/mL).
There is no single PSA number that can definitively say “cancer” or “no cancer.” The likelihood of prostate cancer generally increases as PSA rises, but benign conditions can also produce elevated values.
Historically, 4 ng/mL has often been used as a threshold for considering further evaluation, but some doctors investigate at lower levels depending on age, risk factors and the clinical situation.
So a PSA of 3 is not automatically “safe,” and a PSA of 6 is not automatically cancer.
The number needs context.
Yes.
Benign prostatic hyperplasia (BPH) is a non-cancerous enlargement of the prostate. Because a larger prostate can produce more PSA, BPH may cause an elevated PSA level.
Doctar's article on prostate enlargement and BPH symptoms explains the urinary symptoms that can occur with an enlarged prostate.
This is one reason an elevated PSA should not be interpreted as a cancer diagnosis.
Yes.
Inflammation or infection involving the prostate can increase PSA. A recent urinary problem may therefore complicate interpretation of the result.
This is another reason doctors sometimes repeat PSA testing after considering other possible causes of elevation.
A man with fever, painful urination or significant pelvic symptoms should be medically evaluated rather than assuming the problem is prostate cancer.
No.
This is probably the most important point for anyone receiving an abnormal result.
The American Cancer Society states that PSA testing cannot determine for certain whether prostate cancer is present. If screening results are abnormal, doctors may consider additional evaluation rather than immediately diagnosing cancer.
Depending on the situation, that may include:
repeating the PSA
digital rectal examination
percent-free PSA
other biomarker tests
prostate MRI
prostate biopsy
The appropriate sequence depends on the PSA level, risk factors and clinical findings.
A digital rectal exam (DRE) allows a doctor to feel the prostate through the rectum.
The doctor checks for abnormalities such as unusual hardness, asymmetry or nodules.
A DRE may be used alongside PSA, although the American Cancer Society notes that it is not as good as PSA at finding prostate cancer.
The AUA also says clinicians may use DRE alongside PSA to help establish risk.
An abnormal PSA does not automatically mean a biopsy is the next step.
Doctors may first review the result, medical history, prostate symptoms, medications and previous PSA measurements. In some cases, repeating the test is reasonable because PSA can vary over time.
Additional tests can sometimes help estimate whether a biopsy is worthwhile.
For example, percent-free PSA measures the proportion of PSA circulating freely compared with the total PSA. Other tests include the Prostate Health Index (PHI) and 4Kscore.
MRI can provide detailed images of the prostate and may help identify areas that look suspicious for clinically significant cancer.
It can be particularly useful when a PSA result or other findings raise concern but the next step is uncertain.
If imaging identifies a suspicious area, the urologist may recommend a targeted biopsy.
Doctar's prostate cancer guide discusses PSA testing, biopsy, MRI and other parts of prostate cancer diagnosis.
For a definitive tissue diagnosis, yes, a prostate biopsy is generally required.
During a biopsy, small tissue samples are taken from the prostate and examined by a pathologist for cancer cells. PSA and MRI can indicate that cancer may be present, but they do not replace tissue diagnosis.
Doctar's prostate biopsy recovery guide explains what a biopsy involves and why it may be recommended after abnormal screening.
Not automatically.
The potential benefit of finding a slow-growing prostate cancer becomes smaller when a person's life expectancy is limited by age or other serious illnesses.
The American Cancer Society says men without symptoms who have a life expectancy of less than 10 years generally should not be offered prostate cancer screening because they are unlikely to benefit.
Age alone, however, should not be the only consideration. Overall health and personal preferences matter.
Screening is intended for men without symptoms.
If you already have symptoms such as persistent difficulty urinating, blood in the urine, blood in semen or unexplained pelvic or bone pain, that is no longer simply a screening question. You should speak with a doctor about diagnostic evaluation.
Doctar's information on prostate cancer types covers symptoms, diagnosis and treatment in greater detail.
Urinary symptoms can also come from BPH, infections or other non-cancerous conditions, so symptoms alone cannot establish the diagnosis.
No.
PSA is useful, but it is not perfect.
Some prostate cancers produce relatively little PSA, while non-cancerous conditions can cause high PSA levels. The American Cancer Society specifically notes that a PSA below commonly used thresholds does not completely rule out cancer.
That is why doctors consider the whole clinical picture rather than relying on one blood-test number.
In clinical practice, an abnormal PSA often creates more anxiety than the actual result warrants. A raised PSA is a reason to investigate, not a reason to assume you have cancer.
At-home PSA kits are available in some markets.
They may offer convenience, but they have a limitation: a person may receive a number without having the shared decision-making conversation that should ideally happen before screening.
The American Cancer Society specifically cautions that PSA results are not black and white and recommends discussing screening and results with a healthcare professional.
For most men, the more useful question is not simply “Can I get a PSA test?” but “Is PSA screening appropriate for me, and what would we do with the result?”
Doctar's at-home PSA test guide provides more information about home testing.
There is no universal yearly schedule for every man.
The interval depends on the initial PSA, age, family history, risk factors, overall health and the screening approach used by the clinician.
The AUA recommends regular screening every 2–4 years for many men aged 50–69, with personalised intervals based on risk and PSA levels.
The American Cancer Society similarly bases the interval on the PSA result and individual risk.
A doctor can help determine whether annual, biennial or less frequent testing makes sense.
Before having a PSA test, consider asking:
Am I at average or increased risk?
At my age, what are the possible benefits of screening?
What are the risks of false-positive results and unnecessary treatment?
If my PSA is elevated, what would the next step be?
How often would you recommend repeating the test?
Does my family history change when I should start screening?
These questions make the test more useful because they put the number into context.
Visit Hospital
Near You

Find verified endocrinologists in Lucknow on DOCTAR. Compare experience, ratings, consultation fees and hospital locations, then book an appointment online.
August 22, 2026

Hormonal problems can affect weight, blood sugar, periods, energy levels, growth and several other parts of health. A hormone specialist, usually an endocrinologist, evaluates conditions involving the body's hormone-producing glands.
August 22, 2026

Find and book verified family doctors (general physicians) in Kolkata. Compare 327 doctors by fees (₹200–₹1,500), experience, ratings and hospital affiliation. Same-day appointments available with 316 doctors. Consultations in English, Hindi and Bengali.
August 22, 2026